• Profile
Close

DNA methylation at the mu-1 opioid receptor gene (OPRM1) promoter predicts preoperative, acute, and chronic postsurgical pain after spine fusion

Pharmacogenomics and Personalized Medicine Aug 16, 2017

Chidambaran V, et al. – The researchers evaluated deoxyribonucleic acid methylation at the mu-1 opioid receptor gene (OPRM1) promoter, as a predictor of preoperative, acute, and chronic postsurgical pain (CPSP) as DNA methylation was a potent repressor of gene expression. They identified novel CPSP biomarkers in an active regulatory region of the OPRM1 gene that binds multiple transcription factors. As per the outcomes, inhibition of binding by DNA methylation potentially decreased the OPRM1 gene expression, leading to a decreased response to endogenous and exogenous opioids, and an increased pain experience.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay